Cite

HARVARD Citation

    Maher, T. et al. (n.d.). P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states. Thorax. p. A175. [Online]. 
  
Back to record